
Neovasc NVCN
Annual report 2021
added 12-23-2023
Neovasc Interest Expense 2011-2026 | NVCN
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 133 K | - | - | - | 2.54 K | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 133 K | 2.54 K | 67.8 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Delcath Systems
DCTH
|
-70 K | $ 8.98 | -1.32 % | $ 322 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.41 | 0.38 % | $ 121 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.32 | -2.02 % | $ 168 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 100.97 | 1.78 % | $ 1.28 B | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 62.4 | -1.33 % | $ 3.4 B | ||
|
Medtronic PLC
MDT
|
402 M | $ 86.58 | -0.68 % | $ 111 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 11.72 | -1.26 % | $ 464 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Penumbra
PEN
|
893 K | $ 334.17 | -0.41 % | $ 13 B | ||
|
LENSAR
LNSR
|
660 K | $ 5.56 | -8.4 % | $ 64 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 225.5 | -0.7 % | $ 15.9 B | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 5.15 | -4.63 % | $ 180 M | ||
|
Quanterix Corporation
QTRX
|
157 K | $ 3.82 | -3.05 % | $ 163 M | ||
|
AxoGen
AXGN
|
167 K | $ 32.61 | 2.71 % | $ 1.5 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.56 | -0.19 % | $ 1.13 B | ||
|
Electromed
ELMD
|
78 K | $ 24.7 | 0.86 % | $ 209 M | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.57 | 0.78 % | $ 7.13 M | ||
|
Sensus Healthcare
SRTS
|
683 K | $ 3.96 | -3.65 % | $ 64.7 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.16 | -6.09 % | $ 3.37 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 11.48 | 10.7 % | $ 1.55 B | ||
|
Tandem Diabetes Care
TNDM
|
-13 M | $ 24.51 | -2.31 % | $ 1.67 B | ||
|
Myomo
MYO
|
-668 K | $ 0.7 | -1.83 % | $ 29.3 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.91 | 4.83 % | $ 146 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.91 | -3.4 % | $ 373 M | ||
|
Outset Medical
OM
|
14 M | $ 3.53 | -2.35 % | $ 53.7 K |